Solitary pituitary metastasis from HER2-positive breast cancer
Publication Year 2017-04, Volume 13, Issue #2, Page e181-e184
- Journal Title
- Asia Pac J Clin Oncol
- Publication Type
- Journal Article
- The introduction of anti-HER2 therapy with trastuzumab has seen an increase in frequency of central nervous system metastasis as the site of first recurrence. Here, we present a rare case of a 63-year-old woman who presented with an isolated breast carcinoma pituitary metastasis 5 years following treatment for a high-risk breast cancer. This report underscores the changing nature of HER2-positive disease in the post-trastuzumab era.
- WEHI Research Division(s)
- Stem Cells And Cancer
- PubMed ID
- Publisher's Version
- NHMRC Grants
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2015-11-25 02:39:38Last Modified: 2019-02-15 07:55:16